MktsMarkets

Xenon Pharmaceuticals Inc.
NASDAQ: XENEKey statistics
XENE News
Stories mentioning XENE from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 88,508 | 87,699 | 77,054 | 74,985 | 61,200 | 59,472 | 56,970 | 49,702 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 112,328 | 109,767 | 96,336 | 94,229 | 80,238 | 77,477 | 73,676 | 69,104 |
| Operating Income (Loss) | (112,328) | (109,767) | (96,336) | (94,229) | (72,738) | (77,477) | (73,676) | (69,104) |
| Interest Income | 6,907 | 5,340 | 6,206 | 7,199 | 8,083 | 9,422 | 10,329 | 10,837 |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (104,873) | (104,723) | (90,219) | (85,332) | (64,620) | (69,533) | (63,110) | (58,257) |
| Tax Provision | (2,571) | 538.00 | 677.00 | (626.00) | 427.00 | (3,848) | (320.00) | (333.00) |
| Net Income (Loss) | (102,302) | (105,261) | (90,896) | (84,706) | (65,047) | (65,685) | (62,790) | (57,924) |
| Earnings Per Share (Basic) | (1.17) | (1.33) | (1.15) | (1.07) | (0.83) | (0.84) | (0.81) | (0.75) |
| Earnings Per Share (Diluted) | (1.17) | (1.33) | (1.15) | (1.07) | (0.83) | (0.84) | (0.81) | (0.75) |
| Weighted Average Shares Outstanding (Basic) | 87,346 | 79,254 | 79,248 | 78,953 | 78,688 | 77,895 | 77,926 | 77,671 |
| Weighted Average Shares Outstanding (Diluted) | 87,346 | 79,254 | 79,248 | 78,953 | 78,688 | 77,895 | 77,926 | 77,671 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About XENE
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) is a stock listed on the Nasdaq Stock Market under the ticker symbol XENE. It last traded at $37.75 (Nov 18, 2026, 9:30 AM ET), down 2.7% on the day. That gives Xenon Pharmaceuticals a market capitalisation of $3.6B.
Over the past 52 weeks XENE has traded between $33.38 and $72.66.
For the quarter ended Mar 31, 2026 it reported a net loss of $102.3M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$102.3M |
| Dec 31, 2025 | — | -$105.3M |
| Sep 30, 2025 | — | -$90.9M |
| Jun 30, 2025 | — | -$84.7M |
From Xenon Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…